Market Overview

The global gamma probe device market in terms of revenue was estimated to be worth $ 86.90 Million in 2023 and is poised to reach $ 199.93 Million by 2032, growing at a CAGR of 9.7% from 2024 to 2032.

The gamma probe device market refers to the industry in charge of the development, production, and distribution of gamma probe devices. These are medical devices, specifically certain types of medical instruments designed for detecting gamma radiation that is released from radiopharmaceuticals introduced into a patient. Main uses of these products are in procedures related to surgical oncology, for instance, sentinelling lymph node biopsy and tumour localization. It emits gamma rays from the radioactive tracer, thereby allowing appropriate surgical intervention with minimal destruction of surrounding healthy tissues; it is thus used by surgeons to identify lymph nodes that might contain cancer cells. It has hence become a priority approach in managing cancers like breast cancers, melanomas, and other gastrointestinal cancers.

An increased incidence of cancers, which means an increase in surgical operations that require accurate intratumoral localization, has been the biggest factor in making the gamma probe device market enjoy much growth. This increased demand for minimally invasive surgery further promotes the use of gamma probes, which allows surgeons to perform less invasive but very accurate procedures. This, however, improves surgical outcomes while, at the same time cutting down on patient recovery time and healthcare costs as a whole. The growing interest in precision medicine and personalized treatments approaches further fuelled the expanding usage of gamma probes.

Technological development is regarded as being the key influencer of advancing this gamma probe device market. Recent developments have led to the creation of more sensitive and efficient probes with greater user friendliness. Examples include improvements in ergonomics for the probe designs, better resolution imaging, and in vivo real-time feedback during surgical procedures. The adoption of wireless technology has increased the mobility and facilitation features for surgeons when performing the surgery, making intraoperative usage very smooth and uncomplicated. On the other hand, miniaturization has made gamma probe devices even more useful for a number of applications because they can be easily managed and carried around in operating rooms.

Several factors keep piling up in the growth of gamma probe devices. Increasing pressure of cancer around the globe along with demographic aging continues to fuel demand for more advanced diagnostic and surgical tools. Increased awareness about early detection of cancer and a growing number of health facilities offering high-level cancer treatment all contribute to the expansion of the market. However, these devices have significant costs, and there must be properly trained medical personnel to operate these tools efficiently. Nevertheless, the gamma probe device market will have an upward trend due to more research and development in this field, providing critical support to precision oncology and further improvement in patients' outcomes.

Key Findings

• According to the poll, 34% of hospitals have no such policy in place, whereas 66% of institutions have internal SOPs that govern the hygienic use of probes during surgery. Nearly every centre (97.4%) knew about the sanitary requirements of the probe as shown. 70.3% of the 38 clinics utilise gamma probes that are not sterilised and are protected with sterile plastic. 21.6% do not wear sterile gloves and a sterile protective cover when using unsterilised probes.

Market Dynamics -Market Drivers

Growing Demand for Minimally Invasive Procedures

Minimally invasive surgeries have been and continue to be popular with a high comparative advantage over traditional open surgeries, characterized by shorter recovery times, fewer postoperative complications, and less trauma to the patient. In such procedures, particularly oncology, where it deals with the detection and attempt to totally remove cancerous tissues in the patient's body, gamma probes play a core role. Gamma radiation from intra-patient injection of radiopharmaceuticals, which can be detected by gamma probes and thus allow for accurate localization of sentinel lymph nodes or tumour sites that surgeons then remove, results in an accurate, targeted localization that reduces the amount of normal tissue removed, risks, and improves the success of cancer surgery interventions.

The strong demand for gamma probe devices has been due to the trend towards less invasive treatments. Gamma probes are being used more and more with the rise in the number of minimally invasive oncology procedures, thereby leading to an increase in the efficiency of surgeries as well as improving patient safety. Gamma probe devices also lead to more precise localization of the tumours, which promotes a shift towards more effective treatment that has fewer side effects and enables quicker recovery of patients.

Market Opportunities

Rising Demand for Personalized Medicine

Precision and personalized medicine in oncology lead to tailoring treatments based on the needs of individual patients for better outcomes and fewer side effects. This is possible through several means, among which the gamma probes are an important tool used in surgery to target the detection of tumour cells as well as sentinel lymph nodes. Gamma probes identify gamma radiation emitted by radiotracers, thus helping the surgeon to accurately pinpoint cancerous tissues so that the tumours can be removed more accurately and less invasively. It is in harmony with personalized medicine; treatments directed at a patient's specific type of cancer and their cancer profile are carried out.

Gamma probes would be increasingly used because oncology is becoming more personalized, and these tools augment surgical precision and diminish the damage to surrounding tissue in the healthy tissue. It is this role in the realization of individualized treatment strategies, specifically in more complex cancer surgeries, that will drive uptake and advance personalized oncology practice. In this sense, this ever-growing need underlines the role of gamma probes in advancing the care of malignancy.

Key Findings

• Lightpoint Medical declared in January 2021 that the CE mark had been approved for its robotic gamma probe, SENSEI. Through the lymphatic system, the product can identify sentinel lymph nodes and cancer metastases.
• In August 2021, Telix Pharmaceuticals Limited has teamed up with Lightpoint Medical, a well-known supplier of medical equipment with headquarters in the UK. The latter is an Australian biotechnology company. As per the agreement, both businesses would look into using Lightpoint's SENSEI in combination with Telix's TLX599-CDx. Their goal is to get both prostate cancer surgical devices approved for commercialisation.

Market Restraining Factors

High Cost of Gamma Probe Devices

Devices with gamma probes are very costly, thus their use cannot be widespread in most areas, particularly in developing regions where health care resources are highly constrained. Oncological surgeries, the root locations for tumour and lymph node detection, are the main areas of utilization; hence the costs incurred are not only when purchasing the devices but also on their upkeep and operational support. This makes smaller healthcare facilities, most especially in lesser developed areas not be able to afford advanced technology. They would therefore find it hard to offer precision-guided surgeries that gamma probes enable.

In a developing country the healthcare systems tend to favour more serious needs over expensive specialty tools, thereby limiting further entry into the market. Besides, upkeep and sometimes even calibration and repairs on those devices do not help with the costs involved, making it difficult for resource-limited hospitals to want to invest. High upfront and operating expenses delay gamma probe device adoption in areas where cheap cancer treatment and diagnostics are the next thing, hindering total market growth.

Segmentation Analysis

The market scope is segmented because of by Product Type, by Application, by End-User.

By Product Type

Based on the Product Type of the market is segmented into Handheld Devices, Bench top Devices.

The majority of the market is represented by hand-held gamma probes because of their crucial input into increasing the accuracy of surgeries and increasing the quality of care that patients are provided with during oncological interventions. They have been designed to be portable and easy to use in an operating theatre, where surgeons require quick, precise detection of gamma radiation emitted by radiopharmaceuticals administered to patients. These devices aid in the localization of cancerous tissues and sentinel lymph nodes with utmost accuracy for procedures that lead to a higher degree of accuracy during surgery and superior surgical results. For example, in breast cancer surgeries, gamma probes held in hand are used for locating the sentinel lymph node; hence, there is only a need to biopsy interested areas, reducing trauma to normal tissue.

Bench-top gamma probes are used in a research or more complex setting within the laboratory. It is very sensitive and may provide detailed analysis or experiment that often deals with the measurement of gamma emissions. But it is not used in the clinic because it is not portable.

By Application

Based on the Application of the market is segmented into Sentinel Lymph Node Biopsy (SLNB), Parathyroid Surgery, Tumour Localization.

The most typical application of gamma probes is in sentinel lymph node biopsy, most especially in surgeries such as breast cancer and melanoma. In the conduct of SLNB, a radiopharmaceutical is injected close to the site of the tumour, and the gamma probe can then be used to detect radiation coming from the first point where cancer cells are likely to have travelled-the sentinel lymph node. This kind of localization is very accurate for surgeons, which permits the removal of only the lymph nodes affected by the cancer, thus sparing unnecessary damage to surrounding tissue and allowing better patient care. It can be noted that in the process of treating breast cancers, this technique helps not only in the staging of cancer but also in the decision-making process regarding further treatment.

Gamma probes are also vital tools during parathyroid surgery, where they enable localization of hyperactive parathyroid glands. Localization is crucial for therapeutic surgical intervention, especially in cases of primary hyperparathyroidism. Gamma probes also assist in tumour localization in various cancer surgeries. Thus, gamma probes contribute to higher surgical acuity, where the surgeon knows beforehand the locale for search and surgery of cancerous tissue..

Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America is the biggest market for gamma probe devices primarily because of a strongly established health care system, a high incidence of cancer, and the most advanced surgical procedures. The adoption of new medical technologies by the US patients is considered one of the pioneering ones around the world. Sufficiency in research and development plus major manufacturers in the sector assure a robust environment for further market growth. In addition, the growing cases of minimally invasive surgeries have increased the demand for gamma probes during oncological procedures.

Europe forms a significant market in the context of gamma probes given the high regulatory standards and an inescapable push towards patient safety. Countries like Germany, France, and the UK have always been at the cusp of embracing advanced medical technologies. The growth is also fuelled by an increase in cancer with increased awareness regarding the stage at which the disease needs to be diagnosed and treated. The results from these on-going collaborations are expected to make gamma probe technology even more innovative as the research institutions combined with the manufacturers will enhance and develop applications for surgical oncology.

The Asia-Pacific region is found to be promising for gamma probe devices, primarily driven by better healthcare infrastructure, an increased incidence of cancer, and investments in medical technologies. Improvement in surgical oncology in countries like China, India, and Japan has reasonably been growing the demand for gamma probes. Improvement in the middle-class population and access to healthcare services has also boosted the requirement for advanced tools for surgery in these countries.

In Latin America, the gamma probe device market is in its very nascent stage; however, it is expected to pick up pace with increasing awareness regarding cancer treatment options and development of healthcare infrastructure. The key markets in this region are Brazil and Mexico due to increasing accessibility of advanced medical technologies and rising incidence rates of cancer.

The Middle East and Africa is a smaller but developing market for gamma probe devices. The growth in this region is led by increases in investment in the healthcare infrastructure and rising awareness of cancer diagnosis and treatment. Challenges include economic disparities and differing access levels to healthcare that may slow growth.

List of Companies Profiled

• Dilon Technologies, Inc.
• Lake Shore Cryotronics, Inc.
• Wake Medical Ltd.
• Ziteo Inc.
• Intramedical Imaging LLC
• Berkeley Nucleonics Corporation
• Raditec Medical AG
• Tron Medical Ltd
• BNC Scientific

Key Industry Developments

• In May 2022, Oncovision's Wprobe technology, a range of wireless gamma probes for sentinel lymph node localization—the gold standard in radio-guided surgery—has been acquired by KUBTEC.
• In February 2022, Dr. Doug Adams, a robotic thoracic surgery specialist at Bethesda North Hospital (a division of TriHealth, Ohio), used Lightpoint Medical's revolutionary small robotic gamma probe, SENSEI, to perform a first-of-its-kind lung treatment.

Report Coverage

The report will cover the qualitative and quantitative data on the Global Gamma Probe Device Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Gamma Probe Device market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Gamma Probe Device. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Gamma Probe Device companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Gamma Probe Device Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Gamma Probe Device Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Gamma Probe Device Market valued?
• Which region has the largest share in 2024 for the global Gamma Probe Device Market?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of the Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Gamma Probe Device Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: